JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-O-tetradecanoylphorbol-13-acetate (TPA)

British Journal of Cancer

Volumn 90, Issue 10, 2004, Pages 2017-2024

  Ikezoe, T ^a,b   Yang, Y ^b   Taguchi, H ^b   Koeffler, H P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; c Jun AP 1; JIP 1; JNK; LNCaP; TPA

Indexed keywords

ANDROGEN RECEPTOR; C JUN N TERMINAL KINASE INTERACTING PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTATE SPECIFIC ANTIGEN; PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANDROGEN; CARCINOGEN; CARRIER PROTEIN; MAPK8IP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL PROTECTION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE TARGETING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE; UPREGULATION; WILD TYPE; BIOSYNTHESIS; CELL DIVISION; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMID; PROSTATE TUMOR; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANDROGENS; APOPTOSIS; BLOTTING, WESTERN; CARCINOGENS; CARRIER PROTEINS; CELL DIVISION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; PLASMIDS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; UP-REGULATION;

EID: 2942580969     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601834     Document Type: Article

References (39)

1. Agadir A, Chen G, Bost F, Li Y, Mercola D, Zhang X (1999) Differential effect of retinoic acid on growth regulation by phorbol ester in human cancer cell lines. J Biol Chem 274: 29779-29785
2. Andrews PE, Young CY, Montgomery BT, Tindall DJ (1992) Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line. Cancer Res 52: 1525-1529
3. Behrens A, Sibilia M, Wagner EF (1999) Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21: 326-329
4. Cragg LH, Andreeff M, Feldman E, Roberts J, Murgo A, Winning M, Tombes MB, Roboz G, Kramer L, Grant S (2002) Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D- arabinofuranosylcytosine in patients with refractory acute leukemia. Clin Cancer Res 8: 2123-2133
5. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252
6. Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, Davis RJ (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277: 693-696
7. Engedal N, Korkmaz CG, Saatcioglu F (2002) C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Oncogens 21: 1017-1027
8. Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, Kuroki T, Li L, Yuspa SH, Kazanietz MG (2000) Involvement of protein kinase C δ (PKCδ) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. J Biol Chem 275: 7574-7582
9. Garzotto M, White-Jones M, Jiang Y, Ehleiter D, Liao WC, Haimovitz-Friedman A, Fuks Z, Kolesnick R (1998) 12-O-tetradecanoylphorbol-13- acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res 58: 2260-2264
10. Gaynor R, Simon K, Koeffler HP (1991) Expression of c-jun during macrophage differentiation of HL-60 cells. Blood 77: 2618-2623
11. Glass CK, Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14: 121-141
12. Gschwend JE, Fair WR, Powell CT (2000) Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha. Mol Pharmacol 57: 1224-1234
13. Harding TC, Xue L, Bienemann A, Haywood D, Dickens M, Tolkovsky AM, Uney JB (2001) Inhibition of JNK by overexpression of the JNK binding domain of JIP-1 prevents apoptosis in sympathetic neurons. J Biol Chem 276:4531-4534
14. He H, Wang X, Gorospe M, Holbrook NJ, Trush MA (1999) Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059. Cell Growth Differ 10: 307-315
15. Hisatake J, Kubota T, Hisatake Y, Uskokovic M, Tomoyasu S, Koeffler HP (1999) 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. Cancer Res 59: 4023-4029
16. Hisatake JI, Ikezoe T, Carey M, Holden S, Tomoyasu S, Koeffler HP (2000) Down-regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. Cancer Res 60: 5494-5498
17. Huang W, Shostak Y, Tarr P, Sawyers C, Carey M (1999) Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J Biol Chem 274: 25756-25768
18. Hunter T, Karin M (1992) The regulation of transcription by phosphorylation. Cell 70: 70375-70387
19. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204
20. Kaneki M, Kharbanda S, Pandey P, Yoshida K, Takekawa M, Liou JR, Stone R, Kufe D (1999) Functional role for protein kinase C beta as a regulator of stress-activated protein kinase activation and monocytic differentiation of myeloid leukemia cells. Mol Cell Biol 19: 461-470
21. Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486
22. Koeffler HP (1981) Human myelogenous leukemia: enhanced clonal proliferation in the presence of phorbol diesters. Blood 57: 256-260
23. Koeffler HP, Bar-Eli M, Territo MC (1981) Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Cancer Res 41: 919-926
24. Li P, Nicosia SV, Bai W (2001) Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells. J Biol Chem 276: 20444-20450
25. Mitchell KO, El-Deiry WS (1999) Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol- 13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ 10: 223-230
26. Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J Urol 162: 293-306
27. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, Fair WR (1996) Persistent membrane translocation of protein kinase C alpha during 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 7: 419-428
28. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82
29. Rosenfeld MG, Glass CK (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276: 36865-36868
30. Rovera G, O'Brien TG, Diamond L (1979) Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science 204: 868-870
31. Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Cleave ME (1997) Androgenic induction of prostate-specific antigen gene is repressed by protein - protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem 272: 17485-17494
32. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62: 1217-1226
33. Strair RK, Schaar D, Goodell L, Aisner J, Chin KV, Eid J, Senzon R, Cui XX, Han ZT, Knox B, Rabson AB, Chang R, Conney A (2002) Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate. Clin Cancer Res 8: 2512-2518
34. Takada Y, Hachiya M, Osawa Y, Hasegawa Y, Ando K, Kobayashi Y, Akashi M (1999) 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis is mediated by tumor necrosis factor alpha in human monocytic U937 cells. J Biol Chem 274: 28286-28292
35. Wang X, Martindale JL, Holbrook NJ (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435-39443
36. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ (1998) A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671-1674
37. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95: 15587-15591
38. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215
39. Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ (1999) The JIP group of mitogen-activated protein kinase scaffold proteins. Mol Cell Biol 19: 7245-7254